PXR Ablation Alleviates Diet-induced and Genetic Obesity and Insulin Resistance in Mice

Overview

Journal Diabetes

Specialty Endocrinology

Date 2013 Jan 26

PMID 23349477

Citations 75

Authors

Jinhan He

Jie Gao

Meishu Xu

Songrong Ren

Maja Stefanovic-Racic

Robert Martin ODoherty

Wen Xie

Affiliations

Soon will be listed here.

Abstract

The pregnane X receptor (PXR), along with its sister receptor constitutive androstane receptor (CAR), was initially characterized as a xenobiotic receptor that regulates drug metabolism. In this study, we have uncovered an unexpected endobiotic role of PXR in obesity and type 2 diabetes. PXR ablation inhibited high-fat diet (HFD)-induced obesity, hepatic steatosis, and insulin resistance, which were accounted for by increased oxygen consumption, increased mitochondrial β-oxidation, inhibition of hepatic lipogenesis and inflammation, and sensitization of insulin signaling. In an independent model, introducing the PXR(-/-) allele into the ob/ob background also improved body composition and relieved the diabetic phenotype. The ob/ob mice deficient of PXR showed increased oxygen consumption and energy expenditure, as well as inhibition of gluconeogenesis and increased rate of glucose disposal during euglycemic clamp. Mechanistically, the metabolic benefits of PXR ablation were associated with the inhibition of c-Jun NH2-terminal kinase activation and downregulation of lipin-1, a novel PXR target gene. The metabolic benefit of PXR ablation was opposite to the reported prodiabetic effect of CAR ablation. Our results may help to establish PXR as a novel therapeutic target, and PXR antagonists may be used for the prevention and treatment of obesity and type 2 diabetes.

Citing Articles

The hypolipidemic effect of MI-883, the combined CAR agonist/ PXR antagonist, in diet-induced hypercholesterolemia model.

Dusek J, Mejdrova I, Dohnalova K, Smutny T, Chalupsky K, Krutakova M Nat Commun. 2025; 16(1):1418.

PMID: 39915454 PMC: 11802874. DOI: 10.1038/s41467-025-56642-y.

The fungicide propiconazole induces hepatic steatosis and activates PXR in a mouse model of diet-induced obesity.

Attema B, Kummu O, Krutakova M, Pavek P, Hakkola J, Hooiveld G Arch Toxicol. 2024; 99(3):1203-1221.

PMID: 39718591 DOI: 10.1007/s00204-024-03942-9.

Activation of pregnane X receptor sensitizes alcoholic steatohepatitis by transactivating fatty acid binding protein 4.

Zhang Y, Hu B, Guan S, Li P, Guo Y, Xu P Acta Pharm Sin B. 2024; 14(11):4776-4788.

PMID: 39664417 PMC: 11628830. DOI: 10.1016/j.apsb.2024.08.029.

Identification of human pregnane X receptor antagonists utilizing a high-throughput screening platform.

Lynch C, Margolis R, Niebler J, Travers J, Sakamuru S, Zhao T Front Pharmacol. 2024; 15:1448744.

PMID: 39508053 PMC: 11537999. DOI: 10.3389/fphar.2024.1448744.

B3galt5 functions as a PXR target gene and regulates obesity and insulin resistance by maintaining intestinal integrity.

Zhang J, Huang Y, Li H, Xu P, Liu Q, Sun Y Nat Commun. 2024; 15(1):5919.

PMID: 39004626 PMC: 11247088. DOI: 10.1038/s41467-024-50198-z.

References

Venkatesh M, Wang H, Cayer J, LeRoux M, Salvail D, Das B . In vivo and in vitro characterization of a first-in-class novel azole analog that targets pregnane X receptor activation. Mol Pharmacol. 2011; 80(1):124-35. PMC: 3127530. DOI: 10.1124/mol.111.071787. View

Weiser M, Cabanillas M, Konopleva M, Thomas D, Pierce S, Escalante C . Relation between the duration of remission and hyperglycemia during induction chemotherapy for acute lymphocytic leukemia with a hyperfractionated cyclophosphamide, vincristine, doxorubicin, and dexamethasone/methotrexate-cytarabine regimen. Cancer. 2004; 100(6):1179-85. DOI: 10.1002/cncr.20071. View

Dong B, Saha P, Huang W, Chen W, Abu-Elheiga L, Wakil S . Activation of nuclear receptor CAR ameliorates diabetes and fatty liver disease. Proc Natl Acad Sci U S A. 2009; 106(44):18831-6. PMC: 2773998. DOI: 10.1073/pnas.0909731106. View

Cheng J, Krausz K, Tanaka N, Gonzalez F . Chronic exposure to rifaximin causes hepatic steatosis in pregnane X receptor-humanized mice. Toxicol Sci. 2012; 129(2):456-68. PMC: 3491956. DOI: 10.1093/toxsci/kfs211. View

Kodama S, Moore R, Yamamoto Y, Negishi M . Human nuclear pregnane X receptor cross-talk with CREB to repress cAMP activation of the glucose-6-phosphatase gene. Biochem J. 2007; 407(3):373-81. PMC: 2275060. DOI: 10.1042/BJ20070481. View

Luo G, Cunningham M, Kim S, Burn T, Lin J, Sinz M . CYP3A4 induction by drugs: correlation between a pregnane X receptor reporter gene assay and CYP3A4 expression in human hepatocytes. Drug Metab Dispos. 2002; 30(7):795-804. DOI: 10.1124/dmd.30.7.795. View

Lindley C, Hamilton G, McCune J, Faucette S, Shord S, Hawke R . The effect of cyclophosphamide with and without dexamethasone on cytochrome P450 3A4 and 2B6 in human hepatocytes. Drug Metab Dispos. 2002; 30(7):814-22. DOI: 10.1124/dmd.30.7.814. View

Das B, Madhukumar A, Anguiano J, Kim S, Sinz M, Zvyaga T . Synthesis of novel ketoconazole derivatives as inhibitors of the human Pregnane X Receptor (PXR; NR1I2; also termed SXR, PAR). Bioorg Med Chem Lett. 2008; 18(14):3974-7. DOI: 10.1016/j.bmcl.2008.06.018. View

Vallerie S, Hotamisligil G . The role of JNK proteins in metabolism. Sci Transl Med. 2010; 2(60):60rv5. DOI: 10.1126/scitranslmed.3001007. View

10.

Kodama S, Koike C, Negishi M, Yamamoto Y . Nuclear receptors CAR and PXR cross talk with FOXO1 to regulate genes that encode drug-metabolizing and gluconeogenic enzymes. Mol Cell Biol. 2004; 24(18):7931-40. PMC: 515037. DOI: 10.1128/MCB.24.18.7931-7940.2004. View

11.

Huang J, Jia Y, Fu T, Viswakarma N, Bai L, Rao M . Sustained activation of PPARα by endogenous ligands increases hepatic fatty acid oxidation and prevents obesity in ob/ob mice. FASEB J. 2011; 26(2):628-38. PMC: 3290446. DOI: 10.1096/fj.11-194019. View

12.

Blumberg B, Sabbagh Jr W, Juguilon H, Bolado Jr J, van Meter C, Ong E . SXR, a novel steroid and xenobiotic-sensing nuclear receptor. Genes Dev. 1998; 12(20):3195-205. PMC: 317212. DOI: 10.1101/gad.12.20.3195. View

13.

Howe K, Sanat F, Thumser A, Coleman T, Plant N . The statin class of HMG-CoA reductase inhibitors demonstrate differential activation of the nuclear receptors PXR, CAR and FXR, as well as their downstream target genes. Xenobiotica. 2011; 41(7):519-29. DOI: 10.3109/00498254.2011.569773. View

14.

Orellana-Gavalda J, Herrero L, Malandrino M, Paneda A, Rodriguez-Pena M, Petry H . Molecular therapy for obesity and diabetes based on a long-term increase in hepatic fatty-acid oxidation. Hepatology. 2011; 53(3):821-32. DOI: 10.1002/hep.24140. View

15.

Preiss D, Sattar N . Statins and the risk of new-onset diabetes: a review of recent evidence. Curr Opin Lipidol. 2011; 22(6):460-6. DOI: 10.1097/MOL.0b013e32834b4994. View

16.

Xie W, Barwick J, Downes M, Blumberg B, Simon C, Nelson M . Humanized xenobiotic response in mice expressing nuclear receptor SXR. Nature. 2000; 406(6794):435-9. DOI: 10.1038/35019116. View

17.

Gao J, He J, Shi X, Stefanovic-Racic M, Xu M, ODoherty R . Sex-specific effect of estrogen sulfotransferase on mouse models of type 2 diabetes. Diabetes. 2012; 61(6):1543-51. PMC: 3357292. DOI: 10.2337/db11-1152. View

18.

Takasu N, Yamada T, Miura H, Sakamoto S, Korenaga M, Nakajima K . Rifampicin-induced early phase hyperglycemia in humans. Am Rev Respir Dis. 1982; 125(1):23-7. DOI: 10.1164/arrd.1982.125.1.23. View

19.

Huang H, Wang H, Sinz M, Zoeckler M, Staudinger J, Redinbo M . Inhibition of drug metabolism by blocking the activation of nuclear receptors by ketoconazole. Oncogene. 2006; 26(2):258-68. DOI: 10.1038/sj.onc.1209788. View

20.

Bhalla S, Ozalp C, Fang S, Xiang L, Kemper J . Ligand-activated pregnane X receptor interferes with HNF-4 signaling by targeting a common coactivator PGC-1alpha. Functional implications in hepatic cholesterol and glucose metabolism. J Biol Chem. 2004; 279(43):45139-47. DOI: 10.1074/jbc.M405423200. View